You are here:
Drug trials
#

Drug trials

Get Alerts

Articles

View all

Slow approvals put India's clinical trials at risk

Feb 13, 2013

Slow approvals put India's clinical trials at risk

Drugs firms complain that sluggish bureaucracy in New Delhi and a lack of legal clarity on how to conduct clinical trials have created a climate of regulatory uncertainty in the market. #HowThisWorks #Pharma #Drug trials #Litigataion #Drugmakers
Illegal drug trials: Human rights body issues notice to Centre

Feb 07, 2013

Illegal drug trials: Human rights body issues notice to Centre

The National Human Rights Commission Thursday issued notice to the union ministry of health and family welfare over the alleged clinical drug trials on 3,479 children in the last five years in three government hospitals in Delhi. #NewsTracker #illegal drug trials
India's poor: Pharma industry's favourite 'guinea pigs'?

Nov 28, 2012

India's poor: Pharma industry's favourite 'guinea pigs'?

India's poor, willingly and unwillingly, have turned out to be the favourite guinea pigs for pharma companies in India and abroad. #HowThisWorks #Pharmaceutical industry #human drug trials

Wire

View all

India's poor: Pharma industry's favourite 'guinea pigs'?

Aug 25, 2014

Alleged Silk Road Creator Ross Ulbricht Hit With Three New Drug and Identity Fraud Charges

On Friday, three new charges were filed against 30-year-old Ross Ulbricht, the alleged drug kingpin and Silk Road operator whose trial is scheduled to begin in November...
India's poor: Pharma industry's favourite 'guinea pigs'?

Aug 29, 2014

J&J, Bayer Aim to Expand Xarelto's Uses

Johnson & Johnson and Bayer announced plans to launch clinical trials of the anticoagulant Xarelto against three new diseases in an ambitious bid to widen the market for a drug poised to exceed $1 billion in sales this year...
India's poor: Pharma industry's favourite 'guinea pigs'?

Aug 07, 2014

FDA Moves On Tekmira's Ebola Drug While Sarepta's Sits Unused

As the WHO plans a medical ethics meeting next week on the use of early-stage Ebola drugs, the FDA releases part of a hold on Tekmira's clinical trials while Sarepta's DoD-supported drug sits dormant. How will companies conduct Phase 2 trials if it's...